FlexTouch: A prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1 U), medium- (40 U), and high- (80 U) dose settings

Journal of Diabetes Science and Technology

Volumn 5, Issue 5, 2011, Pages 1195-1199

  Wielandt, Jakob Oest ^a   Niemeyer, Marcus ^a   Hansen, Marianne Rye ^a   Bucher, Ditlef ^a   Thomsen, Niels Bjerrum ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Accuracy; Diabetes; FlexTouch; Insulin; Prefilled pen

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEM; HUMAN; INSTRUMENTATION; REPRODUCIBILITY; SUBCUTANEOUS DRUG ADMINISTRATION;

DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; REPRODUCIBILITY OF RESULTS;

EID: 80052995464     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500525     Document Type: Article

References (22)

1. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med. 1999;106(5):57-8, 61-4, 68.
2. IMS Health. Estimated number of patients using FlexPen®, based on worldwide sales in number of packs sold, IMS world wide data Q3 2008 and daily defined dosage (DDD) for insulin as issued by WHO. 2008.
3. Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract. 1995;41(2):169-75.
4. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20(3):292-8.
5. Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005;27 Suppl B:S89-100.
6. Mollema ED, Snoek FJ, Adèr HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51(5):665-72.
7. Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med. 2001;18(8):671-4.
8. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract. 1999;46(3):239-46.
9. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, eficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995;28(3):173-7.
10. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila). 2004;43(1):69-74.
11. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999;22(1):137-40.
12. Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child. 1998;79(1):59-62.
13. Asakura T, Seino H, Kageyama M, Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin. 2008;24(5):1429-34.
14. Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A. Diferences in the dose accuracy of insulin pens. J Diabetes Sci Technol. 2008;2(3):478-81.
15. Pfützner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin. 2008;24(9):2545-9.
16. Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res. 2005;8:33-40.
17. Sommavilla B, Jørgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2223-32.
18. Weise A, Pfützner JW, Borig J, Pfützner AM, Safinowski M, Hänel H, Musholt PB, Pfützner A. Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Technol. 2009;3(1):149-53.
19. International Standardization Organization. ISO 11608-1:2000. Pen-injectors for medical use - part 1: pen-injectors - requirements and test methods.
20. Pfützner A. FlexPen for the delivery of insulin: accuracy, injection force and patient preference. Expert Rev Med Devices. 2009;6(2):115-23.
21. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28(10):1712-25.
22. Lee IT, Liu HC, Liau YJ, Lee WJ, Huang CN, Sheu WH. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients. J Eval Clin Pract. 2009;15(4):699-703.